RecruitingNCT07124572

Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

500 participants

Start Date

Oct 1, 2022

Study Type

OBSERVATIONAL

Conditions

Thyroid Associated Ophthalmopathy

Summary

This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.

Eligibility

Min Age: 7 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Imaging and ocular examinations for people with thyroid associated ophthalmopathy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 7 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERImaging and ocular examinations

2D and 3D Facial photography, blinking videos, orbital CT and MRI images, fundus images and images of nine gaze positions are taken. Clinical information is recorded. Quality of life is assessed. Ocular examinations, such as visual acuity, levator function, exophthalmos measurement, strabismus test, visual field examination, axial length measurement, OCT, OCTA are made.